{"id":"https://openalex.org/W2018929164","doi":"https://doi.org/10.1097/00004850-200401000-00006","title":"Schizophrenia and osteoporosis","display_name":"Schizophrenia and osteoporosis","publication_year":2003,"publication_date":"2003-12-11","ids":{"openalex":"https://openalex.org/W2018929164","doi":"https://doi.org/10.1097/00004850-200401000-00006","mag":"2018929164","pmid":"https://pubmed.ncbi.nlm.nih.gov/15101568"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-200401000-00006","doi":"https://doi.org/10.1097/00004850-200401000-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-200401000-00006","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012241596","display_name":"Michael E. J. Lean","orcid":"https://orcid.org/0000-0003-2216-0083","observed_orcids":["https://orcid.org/0000-0003-2216-0083"]},"institutions":[{"id":"https://openalex.org/I2800666604","display_name":"Glasgow Royal Infirmary","ror":"https://ror.org/00bjck208","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399","https://openalex.org/I2800666604"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Mike Lean","raw_affiliation_strings":["Department of Human Nutrition, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK. mej.lean@clinmed.gla.ac.uk","Conflict of interest: G.D.S. was previously employed by the Janssen Research Foundation (Belgium)","requests for reprints to Mike Lean, Department of Human Nutrition, University of Glasgow, Glasgow Royal Infirmary, Glasgow G31 2ER, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Nutrition, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK. mej.lean@clinmed.gla.ac.uk","institution_ids":["https://openalex.org/I2800666604","https://openalex.org/I7882870"]},{"raw_affiliation_string":"Conflict of interest: G.D.S. was previously employed by the Janssen Research Foundation (Belgium)","institution_ids":[]},{"raw_affiliation_string":"requests for reprints to Mike Lean, Department of Human Nutrition, University of Glasgow, Glasgow Royal Infirmary, Glasgow G31 2ER, UK","institution_ids":["https://openalex.org/I2800666604","https://openalex.org/I7882870"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109195038","display_name":"Goedele De Smedt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Goedele De Smedt","raw_affiliation_strings":["Tibotec-Virco NV, Mechelen, Belgium","Conflict of interest: G.D.S. was previously employed by the Janssen Research Foundation (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec-Virco NV, Mechelen, Belgium","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: G.D.S. was previously employed by the Janssen Research Foundation (Belgium)","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5012241596"],"corresponding_institution_ids":["https://openalex.org/I2800666604","https://openalex.org/I7882870"],"apc_list":null,"apc_paid":null,"fwci":0.5338,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.67014098,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"19","issue":"1","first_page":"31","last_page":"35"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.07090000063180923,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11219","display_name":"Bone Metabolism and Diseases","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/osteoporosis","display_name":"osteoporosis","score":1.0},{"id":"https://openalex.org/keywords/amenorrhea","display_name":"amenorrhea","score":0.7459999918937683},{"id":"https://openalex.org/keywords/bone-health","display_name":"bone health","score":0.4350000023841858},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.7279999852180481},{"id":"https://openalex.org/keywords/metabolic-monitoring","display_name":"metabolic monitoring","score":0.44999998807907104},{"id":"https://openalex.org/keywords/untreated-schizophrenia","display_name":"untreated schizophrenia","score":0.39399999380111694}],"concepts":[{"id":"https://openalex.org/C2781401123","wikidata":"https://www.wikidata.org/wiki/Q1433936","display_name":"Hyperprolactinaemia","level":4,"score":0.9269551038742065},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.8549577593803406},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7459506988525391},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6962288618087769},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6268007755279541},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.5198700428009033},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5010404586791992},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.45832574367523193},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3802167475223541},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.05435106158256531},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D001842","descriptor_name":"Bone and Bones","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006966","descriptor_name":"Hyperprolactinemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D010024","descriptor_name":"Osteoporosis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D010024","descriptor_name":"Osteoporosis","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D011388","descriptor_name":"Prolactin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004850-200401000-00006","doi":"https://doi.org/10.1097/00004850-200401000-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-200401000-00006","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:15101568","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15101568","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1821837697","https://openalex.org/W1998673996","https://openalex.org/W2001200601","https://openalex.org/W2008658045","https://openalex.org/W2009394319","https://openalex.org/W2010764223","https://openalex.org/W2015837785","https://openalex.org/W2018442412","https://openalex.org/W2019282933","https://openalex.org/W2020730609","https://openalex.org/W2026609897","https://openalex.org/W2048511626","https://openalex.org/W2057910453","https://openalex.org/W2071684462","https://openalex.org/W2074741489","https://openalex.org/W2077431656","https://openalex.org/W2101052738","https://openalex.org/W2125098359","https://openalex.org/W2131348723","https://openalex.org/W2146597964","https://openalex.org/W2152953527","https://openalex.org/W2167821196","https://openalex.org/W2407333258","https://openalex.org/W2413919913"],"related_works":["https://openalex.org/W2148198817","https://openalex.org/W7095711157","https://openalex.org/W2055219683","https://openalex.org/W2149504530","https://openalex.org/W1999016354","https://openalex.org/W2299202580","https://openalex.org/W2021921340","https://openalex.org/W1928401628","https://openalex.org/W2400567797","https://openalex.org/W2156238188"],"abstract_inverted_index":{"Although":[0],"it":[1],"has":[2,20],"been":[3,22],"suggested":[4],"that":[5,56],"antipsychotic-induced":[6,57],"hyperprolactinaemia":[7,58,82],"in":[8,66,73,92],"schizophrenic":[9,67],"patients":[10,31],"may":[11],"lead":[12],"to":[13,38,84],"an":[14,60],"increased":[15],"risk":[16,36,62],"of":[17,42,81,110],"osteoporosis,":[18],"this":[19,97],"not":[21,54],"proven.":[23],"Osteoporosis":[24,69],"is":[25,59,88],"a":[26,79],"multifactorial":[27],"disease,":[28],"and":[29,45,105,108],"untreated":[30],"with":[32],"schizophrenia":[33],"are":[34],"at":[35],"due":[37],"both":[39],"the":[40,43,100],"consequences":[41],"disease":[44],"related":[46],"lifestyle":[47],"factors.":[48],"Evidence":[49],"from":[50],"available":[51],"studies":[52],"does":[53],"show":[55],"independent":[61],"factor":[63],"for":[64,102],"osteoporosis":[65],"patients.":[68,112],"would":[70],"be":[71],"expected":[72],"women":[74],"who":[75],"develop":[76],"amenorrhoea":[77],"as":[78],"result":[80],"secondary":[83],"antipsychotics,":[85],"but":[86],"there":[87],"no":[89],"plausible":[90],"mechanism":[91],"men.":[93],"The":[94],"uncertainty":[95],"over":[96],"issue":[98],"underlines":[99],"need":[101],"full":[103],"medical":[104],"metabolic":[106],"assessment":[107],"monitoring":[109],"psychiatric":[111]},"counts_by_year":[{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}